The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K + currents in neurons
Open accessAbstract
Nearly three million people in the USA suffer traumatic brain injury (TBI) yearly; however, there are no pre- or post-TBI treatment options available. KCNQ2-5 voltage-gated K + channels underlie the neuronal “M current”, which plays a dominant role in the regulation of neuronal excitability. Our strategy towards prevention of TBI-induced brain damage is predicated on the suggested hyper-excitability of neurons induced by TBIs, and the decrease in neuronal excitation upon pharmacological augmentation of M/KCNQ K + currents. Seizures are very common after a TBI, making further seizures and development of epilepsy disease more likely. Our hypothesis is that TBI-induced hyperexcitability and ischemia/hypoxia lead to metabolic stress, cell death and a maladaptive inflammatory response that causes further downstream morbidity. Using the mouse controlled closed-cortical impact blunt TBI model, we found that systemic administration of the prototype M-channel “opener”, retigabine (RTG), 30 min after TBI, reduces the post-TBI cascade of events, including spontaneous seizures, enhanced susceptibility to chemo-convulsants, metabolic stress, inflammatory responses, blood–brain barrier breakdown, and cell death. This work suggests that acutely reducing neuronal excitability and energy demand via M-current enhancement may be a novel model of therapeutic intervention against post-TBI brain damage and dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Retigabine and related ligands shift channel activation toward more negative potentials, increase resting conductance, and suppress burst firing, which translates into robust antidepressant-like and mood-stabilizing effects after chronic social defeat and other stressors [245,252,253].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [252]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Kv7 potassium channel enhancer QO-83, a small-molecule KCNQ/Kv7 channel opener, limits infarct volume, edema, and cognitive decline after ischemic injury while curbing microglial activation, pointing to attenuation of excitotoxic cascades that often follow stress or drug withdrawal [252,255,256,257].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [252]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kv7 openers consistently dampen hyperexcitability, promote stress resilience, and stabilize affective behavior across rodent paradigms.”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [252]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Taylor, C. A., Bell, J. M., Breiding, M. J., & Xu, L. (2017) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6609a1 · Cited by 2,328
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“Staining was performed as previously described.(68) For details, see Supplementary Material.”
MethodA novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
Singh, N. A., Charlier, C., Stauffer, D., DuPont, B. R., Leach, R. J., Melis, R., Ronen, G. M., Bjerre, I., Quattlebaum, T., Murphy, J. V., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-25 · Cited by 1,199
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073
The pilocarpine model of temporal lobe epilepsy
Curia, G., Longo, D., Biagini, G., Jones, R. S. G., & Avoli, M. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.04.019 · Cited by 1,041
Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
Neuroinflammation Induces Neurodegeneration.
Kempuraj, D., Thangavel, R., Natteru, P., Selvakumar, G. P., Saeed, D., Zahoor, H., Zaheer, S., Iyer, S. S., & Zaheer, A. (2016) · PubMed · Cited by 872
Microglia in the TBI brain: The good, the bad, and the dysregulated
Loane, D. J., & Kumar, A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2015.08.018 · Cited by 802
Research works printed but not linked: 5
- 10.1097/01.ccm.0000295667.66853.bc · doi:10.1097/01.ccm.0000295667.66853.bc · Paper page
- Chen K, 2006, Cell Mol Immunol, 3, 163
- Kempuraj D, 2016, J Neurol Neurosurg Spine, 1, 1003
- 10.1089/neu.2004.21.1553 · DOI · Paper page
- Bellini G, 2010, GeneReviews
Cited by
Golub, V. M., & Reddy, D. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000375 · Cited by 132
Microvascular changes associated with epilepsy: A narrative review
van Lanen, R. H. G. J., Melchers, S., Hoogland, G., Schijns, O. E. M. G., van Zandvoort, M. A. M. J., Haeren, R. H. L., & Rijkers, K. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211010388 · Cited by 49
Kcnq2/Kv7.2 controls the threshold and bi-hemispheric symmetry of cortical spreading depolarization
Aiba, I., & Noebels, J. L. (2021) · Brain · doi:10.1093/brain/awab141 · Cited by 44
Targeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
“In a mouse model of traumatic brain injury (TBI), ezogabine administered intraperitoneally (i.p.) 30 min after the insult inhibited the cascade of events leading to neuronal hyperexcitability, seizures, blood brain dysfunction, brain inflammation, and cell death [97].”
Control of neuronal excitability by GSK-3beta: epilepsy and beyond.
Jaworski, T. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118745 · Cited by 43
Metadata
- Authors
- Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., M Carver, C., Cavazos, J. E., Brenner, R., Lechleiter, J. D., & Shapiro, M. S.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Department of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX, USA
- Department of Neurology, University of Texas Health San Antonio, San Antonio, TX, USA
- Corresponding author
- Shapiro, Mark S
- ORCID
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2019-07-04
- Volume
- 40
- Issue
- 6
- Pages
- 1256-1273
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC7238379
- OpenAlex
- W2956066042
- Cited by
- 51
- References
- 130
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 14 · 2020: 7 · 2019: 1
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG019316)
- National Cancer Institute (P30CA054174)
- National Institute of Neurological Disorders and Stroke (R01NS065138, R01NS094461)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- traumatic brain injury, KCNQ channels, M-current, retigabine, neuronal hyperexcitability, post-traumatic seizures, epilepsy, hypoxia-ischemia, metabolic stress, neuroinflammation, blood-brain barrier disruption, neuronal cell death, neuroprotection
- MeSH terms
- Brain Injuries, Traumatic, Animals, Anticonvulsants, Carbamates, Mice, Inbred C57BL, Neurons, Phenylenediamines, Mice, KCNQ Potassium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K + currents in neurons. https://app.cochat.ai/papers/10.1177/0271678x19857818
- The paper
- Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., M Carver, C., Cavazos, J. E., Brenner, R., Lechleiter, J. D., & Shapiro, M. S. (2020). Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K + currents in neurons. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x19857818
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.